Download PDF
Angewandte Nuklearmedizin 2025; 48(04): 262-281
DOI: 10.1055/a-2355-6158
Nuklearkardiologie
CME-Fortbildung

Nuklearkardiologie up2date

Nuclear cardiology up2date

Authors

  • Teresa Kiener

  • Christian Pirich

Further Information
Also available at
   Permissions and Reprints

Dieser Artikel soll einen Überblick über den klinischen Stellenwert der wichtigsten nuklearkardiologischen Verfahren bieten und besonders auf die leitliniengerechte Indikationsstellung und Besonderheiten der methodischen Durchführung und Befundung eingehen. Im Fokus stehen dabei die Myokardperfusionsszintigraphie im Kontext der aktuellen ESC-Richtlinien, die Szintigraphie in der kardialen Amyloidose-Abklärung und die Positronenemissionstomographie in der Diagnostik der infektiösen Endokarditis.



Publication History

Article published online:
08 December 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Vrints C, Andreotti F, Koskinas KC. et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J 2024; 45: 3415-3537
    Search in Google Scholar
  • 2 Kiso K, Masuda A, Takanami K. et al. Post-ISCHEMIA Trial Era: Reconsideration of the Role of Nuclear Cardiology in Patients with Chronic Coronary Artery Disease. Ann Nucl Cardiol 2022; 8: 86-90
    Search in Google Scholar
  • 3 Deutsche Gesellschaft für Nuklearmedizin e.V. (DGN). Update: S1-Leitlinie Myokard-Perfusions-SPECT. Nuklearmedizin 2017; 56: N26
    Search in Google Scholar
  • 4 Lindner O, Hacker M, Burchert W. et al. SPECT and PET myocardial perfusion imaging in Austria, Germany, and Switzerland results of the first joint survey of 2021. Eur J Nucl Med Mol Imaging 2023; 50: 3602-3608
    Search in Google Scholar
  • 5 Verberne HJ, Acampa W, Anagnostopoulos C. et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging 2015; 42: 1929-40
    Search in Google Scholar
  • 6 Dorbala S, Ananthasubramaniam K, Armstrong IS. et al. Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging Guidelines: Instrumentation, Acquisition, Processing, and Interpretation. J Nucl Cardiol 2018; 25: 1784-1846
    Search in Google Scholar
  • 7 Hyafil F, Gimelli A, Slart RHJA. et al. EANM procedural guidelines for myocardial perfusion scintigraphy using cardiac-centered gamma cameras. Eur J Hybrid Imaging 2019; 3: 11
    Search in Google Scholar
  • 8 Qiu L, Tan H, Cheng D. et al. The incremental clinical value of cardiac hybrid SPECT/CTA imaging in coronary artery disease. Nucl Med Commun 2018; 39: 469-478
    Search in Google Scholar
  • 9 Boden WE, O'Rourke RA, Teo KK. et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-16
    Search in Google Scholar
  • 10 Maron DJ, Hochman JS, Reynolds HR. et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med 2020; 382: 1395-1407
    Search in Google Scholar
  • 11 Sharir T, Germano G, Kang X. et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001; 42: 831-7
    Search in Google Scholar
  • 12 McLaughlin MG, Danias PG. Transient ischemic dilation: a powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J Nucl Cardiol 2002; 9: 663-7
    Search in Google Scholar
  • 13 Hu LH, Sharir T, Miller RJH. et al. Upper reference limits of transient ischemic dilation ratio for different protocols on new-generation cadmium zinc telluride cameras: A report from REFINE SPECT registry. J Nucl Cardiol 2020; 27: 1180-1189
    Search in Google Scholar
  • 14 Agostini D, Roule V, Nganoa K. et al. First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging 2018; 45: 1079-1090
    Search in Google Scholar
  • 15 de Souza ACDA, Gonçalves BKD, Tedeschi AL. et al. Quantification of myocardial flow reserve using a gamma camera with solid-state cadmium-zinc-telluride detectors: Relation to angiographic coronary artery disease. J Nucl Cardiol 2021; 28: 876-884
    Search in Google Scholar
  • 16 Keam SJ. Flurpiridaz F 18: First Approval. Am J Cardiovasc Drugs 2025; 25: 1-6
    Search in Google Scholar
  • 17 Motwani M, Leslie WD, Goertzen AL. et al. Fully automated analysis of attenuation-corrected SPECT for the long-term prediction of acute myocardial infarction. J Nucl Cardiol 2018; 25: 1353-1360
    Search in Google Scholar
  • 18 Alskaf E, Dutta U, Scannell CM. et al. Deep learning applications in myocardial perfusion imaging, a systematic review and meta-analysis. Inform Med Unlocked 2022; 32: 101055
    Search in Google Scholar
  • 19 de Souza Filho EM, de Amorim Fernandes F, Wiefels C. et al. Machine Learning Algorithms to Distinguish Myocardial Perfusion SPECT Polar Maps. Front Cardiovasc Med 2021; 8: 741667
    Search in Google Scholar
  • 20 Betancur J, Commandeur F, Motlagh M. et al. Deep Learning for Prediction of Obstructive Disease From Fast Myocardial Perfusion SPECT: A Multicenter Study. JACC Cardiovasc Imaging 2018; 11: 1654-1663
    Search in Google Scholar
  • 21 Miller RJH, Slomka PJ. Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends. Semin Nucl Med 2024; 54: 648-657
    Search in Google Scholar
  • 22 Arbelo E, Protonotarios A, Gimeno JR. et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023; 44: 3503-3626
    Search in Google Scholar
  • 23 Dorbala S, Ando Y, Bokhari S. et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2-Evidence Base and Standardized Methods of Imaging. Circ Cardiovasc Imaging 2021; 14: e000029
    Search in Google Scholar
  • 24 Gillmore JD, Maurer MS, Falk RH. et al. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation 2016; 133: 2404-12
    Search in Google Scholar
  • 25 Rettl R, Wollenweber T, Duca F. et al. Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy. Eur Heart J Cardiovasc Imaging 2023; 24: 1019-1030
    Search in Google Scholar
  • 26 Kim SH, Kim YS, Kim SJ. Diagnostic performance of PET for detection of cardiac amyloidosis: A systematic review and meta-analysis. J Cardiol 2020; 76: 618-625
    Search in Google Scholar
  • 27 Spielvogel CP, Haberl D, Mascherbauer K. et al. Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study. Lancet Digit Health 2024; 6: e251-e260
    Search in Google Scholar
  • 28 Delgado V, Marsan NA, de Waha S. et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44: 3948-4042
    Search in Google Scholar
  • 29 Abikhzer G, Treglia G, Pelletier-Galarneau M. et al. EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0. Eur J Nucl Med Mol Imaging.. 2025; 52: 510-538
    Search in Google Scholar
  • 30 Ten Hove D, Slart RHJA, Sinha B. et al. F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization. Curr Cardiol Rep 2021; 23: 130
    Search in Google Scholar
  • 31 Erba PA, Lancellotti P, Vilacosta I. et al. Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging 2018; 45: 1795-1815
    Search in Google Scholar
  • 32 Roll W, Faust A, Hermann S. et al. Infection Imaging: Focus on New Tracers?. J Nucl Med 2023; 64 (Suppl. 02) 59S-67S
    Search in Google Scholar